KMD Bioscience protein department combines our protein expression systems: prokaryotic expression systems, yeast expression systems, ma...
Read MoreWith the development of biotechnology, high-quality, high-specificity antibodies not only become an effective tool for protein identifi...
Read MoreStable Cell Line refers to the sustained and stable expression of a specific gene in a cell or interference with specific gene expressi...
Read More2019 novel coronavirus(2019-nCoV) infection has attracted worldwide attention since the end of 2019. SARS-CoV-2 is a novel virus that f...
Read MoreExpression of recombinant proteins in E. coli is often the fastest and most cost-effective solution for recombinant protein production. KMD Bioscience leverages ...
Read MoreKMD Bioscience has extensive experiences of antibody development. Our scientists can provide comprehensive antibody downstream engineering services, including an...
Read MoreKMD Bioscience has extensive experiences in antibody production, including monoclonal and polyclonal antibody production. We promise to provide high-performance ...
Read MoreKMD Bioscience offers custom alpaca polyclonal antibody and monoclonal antibody production services to the scientific community. Our capabilities enable us to pr...
Read MoreKMD Bioscience can provide two monoclonal antibody production protocols to meet clients' different needs: 1. Cell fusion technique: including mouse hybridoma...
Read MoreKMD Bioscience has established and perfected four major protein expression platforms: Prokaryotic Expression Platform, Mammalian Cell Protein Expression Platform...
Read MoreKMD Bioscience Ltd. is located in Wuqing District, northwest of Tianjin, China. KMD Bioscience is a comprehensive innovative technology application enterprise integrating R&D, production and sales.
Read MoreThe 2019 new coronavirus disease (COVID-19) epidemic caused by the virus SARS-CoV-2 is the third major epidemic in the past 20 years. SARS-CoV-2 is a member of the Coronaviridae family li...
Read More2019 novel coronavirus(2019-nCoV) infection has attracted worldwide attention since the end of 2019. The epidemic situation in many countries such as American has shown a rapid growth tre...
Read MoreDespite the existence of a preventive vaccine, chronic infection with Hepatitis B virus (HBV) affects more than 250 million people and represents a major global cause of hepatocellular ca...
Read MoreATLANTA - Researchers at the Yerkes National Primate Research Center and the Emory Vaccine Center (EVC) are first to show a new adjuvant, 3M-052, helps induce long-lasting immunity agains...
Read More